D-ALBA Front-Line Sequential Treatment of Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients With Dasatinib and the Bispecific Monoclonal Antibody Blinatumomab
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Blinatumomab (Primary) ; Dasatinib (Primary) ; Prednisone
- Indications Acute lymphoblastic leukaemia
- Focus Therapeutic Use
- 21 Nov 2016 Planned End Date changed from 1 Dec 2019 to 1 Jun 2020.
- 21 Nov 2016 Planned primary completion date changed from 1 Dec 2019 to 1 Jun 2020.
- 21 Nov 2016 Planned initiation date changed from 1 Jun 2016 to 1 Dec 2016.